Author

Maxime Pellegrin

University Hopsital of Lausanne - Cited by 921

Biography

Dr. Maxime Pellegrin is from Division of Angiology, University Hospital of Lausanne, Lausanne, located in Switzerland. He is also specialized in Atherosclerosis, peripheral artery disease, Endothelial Function, Cardiovascular, Angiology and Hypertension. He published 28 articles in good journal and the articles are informative and got good citations.
Title
Cited by
Year
Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome
P Menu, M Pellegrin, JF Aubert, K Bouzourene, A Tardivel, L Mazzolai, ...Cell death & disease 2 (3), e137-e137, 2011201
279
2011
Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine
J Nussberger, JF Aubert, K Bouzourene, M Pellegrin, D Hayoz, ...Hypertension 51 (5), 1306-1311, 2008200
172
2008
Long-term exercise stabilizes atherosclerotic plaque in ApoE knockout mice
M Pellegrin, C Miguet-Alfonsi, K Bouzourene, JF Aubert, V Deckert, ...Medicine & Science in Sports & Exercise 41 (12), 2128-2135, 2009200
61
2009
56
2007
Fluorine MR imaging of inflammation in atherosclerotic plaque in vivo
RB Van Heeswijk, M Pellegrin, U Flögel, C Gonzales, JF Aubert, ...Radiology 275 (2), 421-429, 2015201
48
2015
Chemical shift encoding (CSE) for sensitive fluorine‐19 MRI of perfluorocarbons with complex spectra
RB van Heeswijk, R Colotti, E Darçot, J Delacoste, M Pellegrin, D Piccini, ...Magnetic resonance in medicine 79 (5), 2724-2730, 2018201
21
2018
Voluntary exercise stabilizes established angiotensin II-dependent atherosclerosis in mice through systemic anti-inflammatory effects
M Pellegrin, JF Aubert, K Bouzourene, C Amstutz, L MazzolaiPLoS One 10 (11), e0143536, 2015201
21
2015
Experimental peripheral arterial disease: new insights into muscle glucose uptake, macrophage, and T‐cell polarization during early and late stages
M Pellegrin, K Bouzourene, C Poitry‐Yamate, V Mlynarik, F Feihl, ...Physiological reports 2 (2), e00234, 141
20
2014
Ultra-high-resolution 3D imaging of atherosclerosis in mice with synchrotron differential phase contrast: a proof of concept study
G Bonanno, S Coppo, P Modregger, M Pellegrin, A Stuber, M Stampanoni, ...Scientific reports 5 (1), 11980, 2015201
18
2015
Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent
AJ Cloux, D Aubry, M Heulot, C Widmann, O ElMokh, F Piacente, M Cea, ...Oncotarget 10 (62), 6723, 2019201
16
2019
Intravital microscopy reveals endothelial dysfunction in resistance arterioles in Angiotensin II-induced hypertension
SC Schäfer, M Pellegrin, C Wyss, JF Aubert, J Nussberger, D Hayoz, ...Hypertension research 35 (8), 855-861, 2012201
13
2012
Long-term swimming exercise does not modulate the Akt-dependent endothelial nitric oxide synthase phosphorylation in healthy mice
M Pellegrin, C Miguet-Alfonsi, A Berthelot, L Mazzolai, P LaurantCanadian journal of physiology and pharmacology 89 (1), 72-76, 202
11
2011
Angiotensin II as an inducer of atherosclerosis: Evidence from mouse studies
M Pellegrin, L MazzolaiJournal of Clinical and Experimental Cardiology 1 (S1), 2013201
10
2013
Towards Quantification of Inflammation in Atherosclerotic Plaque in the Clinic–Characterization and Optimization of Fluorine-19 MRI in Mice at 3 T
Towards Quantification of Inflammation in Atherosclerotic Plaque in the Clinic–Characterization and Optimization of Fluorine-1 MRI in Mice at 3 TE Darçot, R Colotti, M Pellegrin, A Wilson, S Siegert, K Bouzourene, ...Scientific reports (1), 17488, 20120
9
2019
Running exercise and angiotensin II type I receptor blocker telmisartan are equally effective in preventing angiotensin II-mediated vulnerable atherosclerotic lesions
M Pellegrin, J Szostak, K Bouzourène, JF Aubert, A Berthelot, ...Journal of cardiovascular pharmacology and therapeutics 22 (2), 159-16, 2017201
8
2017
Connexin37‐dependent mechanisms selectively contribute to modulate angiotensin II‐mediated hypertension
L Le Gal, M Pellegrin, T Santoro, L Mazzolai, A Kurtz, P Meda, C Wagner, ...Journal of the American Heart Association (), e01023, 2019201
8
2019
Exercise aggravates cardiovascular risks and mortality in rats with disrupted nitric oxide pathway and treated with recombinant human erythropoietin
F Meziri, D Binda, S Touati, M Pellegrin, A Berthelot, RM Touyz, P LaurantEuropean journal of applied physiology 111, 1929-193, 2011201
8
2011
Supramaximal intensity hypoxic exercise and vascular function assessment in mice
J Lavier, M Beaumann, S Ménetrey, L Mazzolai, AC Peyter, M Pellegrin, ...JoVE (Journal of Visualized Experiments), e58708, 2019201
6
2019